Global Advanced Infusion Systems Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Advanced Infusion Systems Market is presumed to reach the market size of nearly USD 17.85 Billion by 2032 from USD 8.44 Billion in 2023 with a CAGR of 8.68% under the study period 2024-2032.

Advanced infusion systems are medical devices used to deliver fluids, such as medications, nutrients, and blood products, directly into a patient's bloodstream in a controlled manner. These systems include programmable infusion pumps, smart intravenous (IV) sets, and software for monitoring and adjusting flow rates. They enhance patient care by ensuring accurate dosing, reducing the risk of medication errors, and allowing for precise control of infusion therapy. These systems are vital in various clinical settings, including hospitals, outpatient clinics, and home care.

MARKET DYNAMICS

The advanced infusion systems market is driven by the rising burden of chronic diseases and the growing demand for precise and controlled drug delivery methods. As the incidence of conditions like diabetes, cancer, and cardiovascular diseases rises, the need for effective infusion therapies becomes more critical. Advanced infusion systems offer significant accuracy, safety, and patient comfort benefits, making them indispensable in modern healthcare settings. Technological advancements in infusion pumps, such as developing smart pumps with integrated real-time monitoring and adjustment software, further drive market growth. The aging population and the subsequent increase in age-related health conditions also contribute to the rising market growth.

The shift towards home healthcare and outpatient care services also boosts the adoption of portable and user-friendly infusion devices. Government initiatives and favorable reimbursement policies for infusion therapies are crucial in promoting market growth. Moreover, the increasing focus on improving healthcare infrastructure and the growing awareness about the benefits of advanced infusion technologies among healthcare providers and patients drive the market forward. However, the high cost of advanced infusion systems and the requirement for thorough training of healthcare professionals may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Advanced Infusion Systems. The growth and trends of Advanced Infusion Systems industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Advanced Infusion Systems market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Patient-Controlled Analgesia Pump
Volumetric Infusion System
Syringe Infusion System
Ambulatory Infusion System
Disposable Infusion System
Elastomeric Infusion System
Implantable Infusion System

By Application

Diabetes
Asthma
Chemotherapy
Pain Management
Clinical Nutrition

By End-User

Ambulatory Surgical Centers
Bedside
Hospitals
Diagnostic Centers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Advanced Infusion Systems market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Advanced Infusion Systems market include Hospira Inc., Animas Corporation, Terumo Corporation, F.Hoffmann-La Roche Ltd., AngioDynamics Inc., B.Braun Melsungen AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112115067

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ADVANCED INFUSION SYSTEMS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ADVANCED INFUSION SYSTEMS MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Patient-Controlled Analgesia Pump Historic and Forecast Sales By Regions
5.4. Volumetric Infusion System Historic and Forecast Sales By Regions
5.5. Syringe Infusion System Historic and Forecast Sales By Regions
5.6. Ambulatory Infusion System Historic and Forecast Sales By Regions
5.7. Disposable Infusion System Historic and Forecast Sales By Regions
5.8. Elastomeric Infusion System Historic and Forecast Sales By Regions
5.9. Implantable Infusion System Historic and Forecast Sales By Regions

6. GLOBAL ADVANCED INFUSION SYSTEMS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Diabetes Historic and Forecast Sales By Regions
6.4. Asthma Historic and Forecast Sales By Regions
6.5. Chemotherapy Historic and Forecast Sales By Regions
6.6. Pain Management Historic and Forecast Sales By Regions
6.7. Clinical Nutrition Historic and Forecast Sales By Regions

7. GLOBAL ADVANCED INFUSION SYSTEMS MARKET ANALYSIS BY END-USER

7.1. Overview By End-User
7.2. Historical and Forecast Data Analysis By End-User
7.3. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
7.4. Bedside Historic and Forecast Sales By Regions
7.5. Hospitals Historic and Forecast Sales By Regions
7.6. Diagnostic Centers Historic and Forecast Sales By Regions

8. GLOBAL ADVANCED INFUSION SYSTEMS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ADVANCED INFUSION SYSTEMS COMPANIES

9.1. Advanced Infusion Systems Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ADVANCED INFUSION SYSTEMS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Hospira Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Animas Corporation
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Terumo Corporation
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. F.Hoffmann-La Roche Ltd.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. AngioDynamics Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. B.Braun Melsungen AG
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies